Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53

Parant, John, Chavez-Reyes, Arturo, Little, Natalie A., Yan, Wen, Reinke, Valerie, Jochemsen, Aart G., Lozano, Guillermina·2001·Nature Genetics
DOI 10.1038/ng714

Cited by (521)

Items 101–200 of 521

  1. MDM2 and MDMX: Alone and together in regulation of p53.
    Miriam Shadfan, Vanessa Lopez-Pajares, Zhi-Min Yuan · 2012 · PubMed
  2. Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
    LeBron, Cynthia, Chen, Lihong, Gilkes, Daniele M, Chen, Jiandong · 2006 · The EMBO Journal
  3. Critical Contribution of the MDM2 Acidic Domain to p53 Ubiquitination
    Hidehiko Kawai, Dmitri Wiederschain, Zhi-Min Yuan · 2003 · Molecular and Cellular Biology
  4. Haploinsufficiency of <i>Mdm2</i> and <i>Mdm4</i> in Tumorigenesis and Development
    Terzian, Tamara, Wang, Yongxing, Van Pelt, Carolyn S., Box, Neil F., Travis, Elisabeth L., Lozano, Guillermina · 2007 · Molecular and Cellular Biology
  5. Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation
    Wang, Yunyuan V., Wade, Mark, Wong, EeTsin, Li, Yao-Cheng, Rodewald, Luo Wei, Wahl, Geoffrey M. · 2007 · Proceedings of the National Academy of Sciences
  6. The p53 family in nervous system development and disease
    W. Bradley Jacobs, David R. Kaplan, Freda D. Miller · 2006 · Journal of Neurochemistry
  7. MdmX Protein Is Essential for Mdm2 Protein-mediated p53 Polyubiquitination
    Xinjiang Wang, Junru Wang, Xuejun Jiang · 2011 · Journal of Biological Chemistry
  8. p53—A Natural Cancer Killer: Structural Insights and Therapeutic Concepts
    Lin Römer, Christian Klein, Alexander Dehner, Horst Kessler, Johannes Büchner · 2006 · Angewandte Chemie International Edition
  9. 14‐3‐3γ binds to MDMX that is phosphorylated by UV‐activated Chk1, resulting in p53 activation
    Yetao Jin, Mu‐Shui Dai, Steven Z. Lu, Yingda Xu, Zhijun Luo, Yingming Zhao, Hua Lu · 2006 · The EMBO Journal
  10. Critical Role for a Central Part of Mdm2 in the Ubiquitylation of p53
    Erik Meulmeester, Ruth Frenk, Robert Kees Stad, Petra de Graaf, Jean‐Christophe Marine, Karen H. Vousden, Aart G. Jochemsen · 2003 · Molecular and Cellular Biology
  11. p53 ancestry: gazing through an evolutionary lens
    Lu, Wan-Jin, Amatruda, James F., Abrams, John M. · 2009 · Nature reviews. Cancer
  12. Mdm2 and MdmX partner to regulate p53
    Xinjiang Wang, Xuejun Jiang · 2012 · FEBS Letters
  13. Identification of ribosomal protein S25 (RPS25)–MDM2–p53 regulatory feedback loop
    Xinyuan Zhang, Wenjing Wang, Hui Wang, M-H Wang, Wenrong Xu, R Zhang · 2012 · Oncogene
  14. Regulation of p53 - insights into a complex process
    Karen A. Boehme, Christine Blattner · 2009 · Critical Reviews in Biochemistry and Molecular Biology
  15. MdmX Is a RING Finger Ubiquitin Ligase Capable of Synergistically Enhancing Mdm2 Ubiquitination
    James Charles Badciong, Arthur L. Haas · 2002 · Journal of Biological Chemistry
  16. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers
    Ruiying Zhao, Sai‐Ching J. Yeung, Jian Chen, Tomoo Iwakuma, Chun‐Hui Su, Bo Chen, Changju Qu, Fanmao Zhang, You‐Tzung Chen, Yu Lin et al. · 2011 · Journal of Clinical Investigation
  17. Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities
    Vivien Landré, Barak Rotblat, Sonia Melino, Francesca Bernassola, Gerry Melino · 2014 · Oncotarget
  18. An Apela RNA-Containing Negative Feedback Loop Regulates p53-Mediated Apoptosis in Embryonic Stem Cells
    Mangmang Li, Hongfeng Gou, Brajendra K. Tripathi, Jing Li Huang, Shunlin Jiang, Wendy Dubois, Tim Waybright, Ming Lei, Jianxin Shi, Ming Zhou et al. · 2015 · Cell stem cell
  19. Genotoxic Stress Induces Coordinately Regulated Alternative Splicing of the p53 Modulators MDM2 and MDM4
    Dawn S. Chandler, Ravi Kumar Singh, Lisa C. Caldwell, Jaquelyn L. Bitler, Guillermina Lozano · 2006 · Cancer Research
  20. MdmX is a substrate for the deubiquitinating enzyme USP2a
    Allende-Vega, N, Sparks, A, Lane, D P, Saville, M K · 2010 · Oncogene
  21. Discovery of Mdm2-MdmX E3 Ligase Inhibitors Using a Cell-Based Ubiquitination Assay
    Herman, Ariel G., Hayano, Miki, Poyurovsky, Masha V., Shimada, Kenichi, Skouta, Rachid, Prives, Carol, Stockwell, Brent R. · 2011 · Cancer Discovery
  22. Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer
    Sharmila Patel, Mark R. Player · 2008 · Expert Opinion on Investigational Drugs
  23. Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?
    Annabella Thomas, Gemma L. Kelly, Andreas Strasser · 2022 · Cell Death and Differentiation
  24. Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation
    Jiang, Man, Pabla, Navjotsin, Murphy, Robert F., Yang, Tianxin, Yin, Xiao-Ming, Degenhardt, Kurt, White, Eileen, Dong, Zheng · 2007 · Journal of Biological Chemistry
  25. Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
    Bin Song, Ping Yang, Shuyu Zhang · 2024 · 癌症：英文版
  26. p53-Independent Effects of Mdm2
    Stephen Bohlman, James J. Manfredi · 2014 · Sub-cellular biochemistry/Subcellular biochemistry
  27. Unleashing the power of p53: lessons from mice and men: Figure 1.
    Masha V. Poyurovsky, Carol L. Prives · 2006 · Genes & Development
  28. Improving cancer therapy by non-genotoxic activation of p53
    Sonia Laı́n, David Philip Lane · 2003 · European Journal of Cancer
  29. Mouse Models of p53 Functions
    Guillermina Lozano · 2009 · Cold Spring Harbor Perspectives in Biology
  30. Significance of HDMX‐S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis
    Frank Bartel, Jördis Schulz, Anja Böhnke, Karen Blümke, Matthias Kappler, Matthias Bache, Hannelore Schmidt, Peter Würl, Helge W. Taubert, Steffen Hauptmann · 2005 · International Journal of Cancer
  31. The Regulation of the p53-mediated Stress Response by MDM2 and MDM4
    Mary Ellen Perry · 2009 · Cold Spring Harbor Perspectives in Biology
  32. The p53 mRNA: an integral part of the cellular stress response
    Lucia Hároníková, Vanesa Olivares‐Illana, Lixiao Wang, Konstantinos Karakostis, Sa Chen, Robin Fåhræus · 2019 · Nucleic Acids Research
  33. Mdm2 and Mdm4 Loss Regulates Distinct p53 Activities
    Juan Barboza, Tomoo Iwakuma, Tamara Terzian, Adel K. El‐Naggar, Guillermina Lozano · 2008 · Molecular Cancer Research
  34. Regulation of p53-MDMX interaction by casein kinase 1 alpha
    Chen, Lihong, Li, Changgong, Pan, Yu, Chen, Jiandong · 2005 · Molecular and Cellular Biology
  35. A New Twist in the Feedback Loop: Stress-Activated MDM2 Destabilization is Required for p53 Activation
    Jayne M. Stommel, Geoffrey M. Wahl · 2005 · Cell Cycle
  36. Killing by Degradation: Regulation of Apoptosis by the Ubiquitin-Proteasome-System
    Ruqaia Abbas, Sarit Larisch · 2021 · Cells
  37. Uncovering Ubiquitin and Ubiquitin-like Signaling Networks
    Alfred C.O. Vertegaal · 2011 · Chemical Reviews
  38. Hdmx Recruitment into the Nucleus by Hdm2 Is Essential for Its Ability to Regulate p53 Stability and Transactivation
    Domenico Migliorini, Davide Danovi, Emanuela Colombo, Roberta Carbone, Pier Giuseppe Pelicci, Jean‐Christophe Marine · 2002 · Journal of Biological Chemistry
  39. The RING domain of Mdm2 can inhibit cell proliferation.
    Jinjun Dang, Mei-Ling Kuo, Christine M. Eischen, Lilia Stepanova, Charles J. Sherr, Martine F. Roussel · 2002 · PubMed
  40. Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target
    Markus J. Riemenschneider, Christiane Brigitte Knobbe-Thomsen, Guido Reifenberger · 2003 · International Journal of Cancer
  41. High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomas
    Yasmine A. Valentin-Vega, Juan Barboza, Gilda P. Chau, Adel K. El‐Naggar, Guillermina Lozano · 2007 · Human Pathology
  42. Validation of MdmX as a therapeutic target for reactivating p53 in tumors
    Garcia, Daniel, Warr, Matthew R., Martins, Carla P., Brown Swigart, Lamorna, Passegué, Emmanuelle, Evan, Gerard I. · 2011 · Genes &amp; Development
  43. Balance of Yin and Yang: Ubiquitylation-Mediated Regulation of p53 and c-Myc
    Mu‐Shui Dai, Yetao Jin, Jayme R. Gallegos, Hua Lu · 2006 · Neoplasia
  44. Spontaneous Tumorigenesis in Mice Overexpressing the p53-Negative Regulator Mdm4
    Xiong, Shunbin, Pant, Vinod, Suh, Young-Ah, Van Pelt, Carolyn S., Wang, Yongxing, Valentin-Vega, Yasmine A., Post, Sean M., Lozano, Guillermina · 2010 · Cancer Research
  45. DNA Damage Induces MDMX Nuclear Translocation by p53-Dependent and -Independent Mechanisms
    Changgong Li, Lihong Chen, Jiandong Chen · 2002 · Molecular and Cellular Biology
  46. MDM4 (MDMX) localizes at the mitochondria and facilitates the p53‐mediated intrinsic‐apoptotic pathway
    Francesca Mancini, Giusy Di Conza, Marsha Pellegrino, Cinzia Rinaldo, Andrea Prodosmo, Simona Giglio, Igea D’Agnano, Fulvio Florenzano, Lara Felicioni, Fiamma Buttitta et al. · 2009 · The EMBO Journal
  47. MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond
    Jean‐Christophe Marine, Aart G. Jochemsen · 2016 · Cold Spring Harbor Perspectives in Medicine
  48. Reviving the guardian of the genome: Small molecule activators of p53
    Daniel Nguyen, Wenjuan Liao, Shelya X. Zeng, Hua Lu · 2017 · Pharmacology & Therapeutics
  49. The role of MDM2 and MDM4 in breast cancer development and prevention
    Sue Haupt, Reshma Vijayakumaran, Panimaya Jeffreena Miranda, Andrew Burgess, Elgene Lim, Ygal Haupt · 2017 · Journal of Molecular Cell Biology
  50. The Mdm network and its regulation of p53 activities: a rheostat of cancer risk
    Eischen, Christine M., Lozano, Guillermina · 2014 · Human Mutation
  51. Roles of HAUSP-mediated p53 regulation in central nervous system development
    Kon, N, Zhong, J, Kobayashi, Y, Li, M, Szabolcs, M, Ludwig, T, Canoll, P D, Gu, W · 2011 · Cell Death &amp; Differentiation
  52. Increased Radioresistance and Accelerated B Cell Lymphomas in Mice with Mdmx Mutations that Prevent Modifications by DNA-Damage-Activated Kinases
    Wang, Yunyuan V., Leblanc, Mathias, Wade, Mark, Jochemsen, Aart G., Wahl, Geoffrey M. · 2009 · Cancer Cell
  53. Phosphorylation of MDMX Mediated by Akt Leads to Stabilization and Induces 14-3-3 Binding
    Lopez-Pajares, Vanessa, Kim, Mihee M., Yuan, Zhi-Min · 2008 · Journal of Biological Chemistry
  54. Mechanisms Underlying Recurrent Genomic Amplification in Human Cancers
    Hisashi Tanaka, Takaaki Watanabe · 2020 · Trends in cancer
  55. Smad Ubiquitylation Regulatory Factor 1/2 (Smurf1/2) Promotes p53 Degradation by Stabilizing the E3 Ligase MDM2
    Jing Nie, Ping Xie, Lin Liu, Guichun Xing, Zhijie Chang, Yuxin Yin, Chunyan Tian, Fuchu He, Lingqiang Zhang · 2010 · Journal of Biological Chemistry
  56. MDMX Promotes Proteasomal Turnover of p21 at G1 and Early S Phases Independently of, but in Cooperation with, MDM2
    Yetao Jin, Shelya X. Zeng, Xiao‐Xin Sun, Hunjoo Lee, Christine Blattner, Zhi‐Xiong Jim Xiao, Hua Lu · 2007 · Molecular and Cellular Biology
  57. Therapeutic targeting of p53 by small molecules
    Galina Selivanova · 2010 · Seminars in Cancer Biology
  58. The role of p53 in developmental syndromes
    Margot E. Bowen, Laura Donatella Attardi · 2019 · Journal of Molecular Cell Biology
  59. What have animal models taught us about the p53 pathway?
    Guillermina Lozano, Gerard P. Zambetti · 2005 · The Journal of Pathology
  60. DNA double-strand breaks: A potential causative factor for mammalian aging?
    Han Li, James R. Mitchell, Paul Hasty · 2008 · Mechanisms of Ageing and Development
  61. Switching mechanisms of cell death in mdm2- and mdm4-null mice by deletion of p53 downstream targets.
    Arturo Chávez‐Reyes, John M. Parant, Lisa L. Amelse, Roberto Montes de Oca Luna, Stanley J. Korsmeyer, Guillermina Lozano · 2003 · PubMed
  62. Crystal Structures of Human MdmX (HdmX) in Complex with p53 Peptide Analogues Reveal Surprising Conformational Changes
    Joerg A. Kallen, A. Goepfert, Anke Blechschmidt, Aude Izaac, Martin Geiser, Gisele Tavares, Paul Ramage, Pascal Furet, Keiichi Masuya, Joanna Hergovich Lisztwan · 2009 · Journal of Biological Chemistry
  63. Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity
    Koji Nomura, Marta Klejnot, Dominika Kowalczyk, Andreas K Hock, Gary J Sibbet, Karen H. Vousden, Danny T. C. Huang · 2017 · Nature Structural & Molecular Biology
  64. Loss of <i>Mdm4</i> Results in <i>p53</i> -Dependent Dilated Cardiomyopathy
    Xiong, Shunbin, Van Pelt, Carolyn S., Elizondo-Fraire, Ana C., Fernandez-Garcia, Belen, Lozano, Guillermina · 2007 · Circulation
  65. MdmX inhibits ARF mediated Mdm2 sumoylation
    Ghosh, Mithua, Weghorst, Karen, Berberich, Steven J. · 2005 · Cell Cycle
  66. Mdm2, but not Mdm4, protects terminally differentiated smooth muscle cells from p53-mediated caspase-3-independent cell death
    Boesten, L S M, Zadelaar, S M, De Clercq, S, Francoz, S, van Nieuwkoop, A, Biessen, E A L, Hofmann, F, Feil, S, Feil, R, Jochemsen, A G et al. · 2006 · Cell Death &amp; Differentiation
  67. Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis
    Michael I. Carr, Stephen N. Jones · 2016 · Translational Cancer Research
  68. Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway
    Bang, Scott, Kaur, Sandeep, Kurokawa, Manabu · 2019 · International Journal of Molecular Sciences
  69. p53 pathway is involved in cell competition during mouse embryogenesis
    Zhang, Guoxin, Xie, Yinyin, Zhou, Ying, Xiang, Cong, Chen, Lai, Zhang, Chenxi, Hou, Xiaoshuang, Chen, Jiong, Zong, Hui, Liu, Geng · 2017 · Proceedings of the National Academy of Sciences
  70. The long and the short of it: the MDM4 tail so far
    Sue Haupt, Javier Octavio Mejía-Hernández, Reshma Vijayakumaran, Simon P. Keam, Ygal Haupt · 2019 · Journal of Molecular Cell Biology
  71. Inhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain
    Brittany L. Cross, Lihong Chen, Qian Cheng, Baozong Li, Zhi-Min Yuan, Jiandong Chen · 2011 · Journal of Biological Chemistry
  72. Hetero-oligomerization with MdmX Rescues the Ubiquitin/Nedd8 Ligase Activity of RING Finger Mutants of Mdm2
    Rajesh Kumar Singh, Saravanakumar Iyappan, Martin Scheffner · 2007 · Journal of Biological Chemistry
  73. The fate of mosaic aneuploid embryos during mouse development
    Daniel A. Lightfoot, Anna Kouznetsova, Ensaf Mahdy, Johannes H. Wilbertz, Christer Höög · 2005 · Developmental Biology
  74. It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
    Che-Pei Kung, Jason D. Weber · 2022 · Frontiers in Cell and Developmental Biology
  75. Phosphorylation and Degradation of MdmX Is Inhibited by Wip1 Phosphatase in the DNA Damage Response
    Zhang, Xinna, Lin, Lin, Guo, Huarong, Yang, Jianhua, Jones, Stephen N., Jochemsen, Aart, Lu, Xiongbin · 2009 · Cancer Research
  76. Regulation of p53 by Mdm2 E3 Ligase Function Is Dispensable in Embryogenesis and Development, but Essential in Response to DNA Damage
    Laura A. Tollini, Aiwen Jin, Jikyoung Park, Yanping Zhang · 2014 · Cancer Cell
  77. p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation
    Tamara Terzian, Enrique C. Torchia, Daisy Dai, Steven E. Robinson, Kazutoshi Murao, Regan A. Stiegmann, Victoria Gonzalez, Glen M. Boyle, Marianne Broome Powell, Pamela M. Pollock et al. · 2010 · Pigment Cell & Melanoma Research
  78. Ribosomal protein S27-like is a physiological regulator of p53 that suppresses genomic instability and tumorigenesis
    Xiufang Xiong, Yongchao Zhao, Fei Tang, Dongping Wei, Daffyd G. Thomas, Xiang Wang, Yang Liu, Pan Zheng, Yi Sun · 2014 · eLife
  79. Wild type p53 reactivation: From lab bench to clinic
    Galina Selivanova · 2014 · FEBS Letters
  80. Distinct roles of Mdm2 and Mdm4 in red cell production
    Maetens, Marion, Doumont, Gilles, Clercq, Sarah De, Francoz, Sarah, Froment, Pascal, Bellefroid, Eric, Klingmuller, Ursula, Lozano, Guillermina, Marine, Jean-Christophe · 2007 · Blood
  81. p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors
    Baozong Li, Qian Cheng, Zhenyu Li, Jiandong Chen · 2010 · Cell Cycle
  82. The Many Faces of MDM2 Binding Partners
    Maurisa F. Riley, Guillermina Lozano · 2012 · Genes & Cancer
  83. The Spatiotemporal Pattern and Intensity of p53 Activation Dictates Phenotypic Diversity in p53-Driven Developmental Syndromes
    Margot E. Bowen, Jacob McClendon, Hannah K. Long, Aryo Sorayya, Jeanine L. Van Nostrand, Joanna Wysocka, Laura Donatella Attardi · 2019 · Developmental Cell
  84. Crippling p53 activities via knock-in mutations in mouse models
    Tomoo Iwakuma, Guillermina Lozano · 2007 · Oncogene
  85. MDMX inhibits the p300/CBP-mediated acetylation of p53
    Sabbatini, Peter, McCormick, Frank · 2002 · DNA and Cell Biology
  86. Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma
    Chunlin Wang, Junyu Wang, Zhenyang Liu, Xiaomei Ma, Xiaowen Wang, Hai Dan Jin, Xiao-Ping Zhang, Da Fu, Lijun Hou, Yicheng Lu · 2014 · Carcinogenesis
  87. p53 in the CNS: Perspectives on Development, Stem Cells, and Cancer
    Susan M. Mendrysa, Sara Ghassemifar, Reem A. Malek · 2011 · Genes & Cancer
  88. MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output
    Lihong Chen, Zhenyu Li, Aleksandra Zwolińska, Matthew A. Smith, Brittany L. Cross, John M. Koomen, Zhi-Min Yuan, Thomas Jenuwein, Jean‐Christophe Marine, Kenneth L. Wright et al. · 2010 · The EMBO Journal
  89. Negative Regulation of p53 Functions by Daxx and the Involvement of MDM2
    Lisa Zhao, Jilin Liu, Gurjit Singh Sidhu, Yuxin Niu, Yue Liu, Ruipeng Wang, Daiqing Liao · 2004 · Journal of Biological Chemistry
  90. A Balancing Act: p53 Activity from Tumor Suppression to Pathology and Therapeutic Implications
    Mengxiong Wang, Laura Donatella Attardi · 2021 · Annual Review of Pathology Mechanisms of Disease
  91. Making sense of ubiquitin ligases that regulate p53
    Abhinav K. Jain, Michelle Craig Barton · 2010 · Cancer Biology & Therapy
  92. Illuminating p53 function in cancer with genetically engineered mouse models
    Patty B. Garcia, Laura Donatella Attardi · 2014 · Seminars in Cell and Developmental Biology
  93. NF-κB inhibits T-cell activation-induced, p73-dependent cell death by induction of MDM2
    Valère Busuttil, Nathalie M Droin, Laura L. McCormick, Francesca Bernassola, Eleonora Candi, Gerry Melino, Douglas R. Green · 2010 · Proceedings of the National Academy of Sciences
  94. MdmX Promotes Bipolar Mitosis To Suppress Transformation and Tumorigenesis in p53-Deficient Cells and Mice
    Matijasevic, Zdenka, Steinman, Heather A., Hoover, Kathleen, Jones, Stephen N. · 2008 · Molecular and Cellular Biology
  95. Tied Up in Loops: Positive and Negative Autoregulation of p53
    Xin Lü · 2009 · Cold Spring Harbor Perspectives in Biology
  96. Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
    Tiffany DeVine, Mu‐Shui Dai · 2013 · Current Pharmaceutical Design
  97. Mdm2: A Regulator of Cell Growth and Death
    Dania Alarcon-Vargas, Shoichi Takahashi, Ze’ev A. Ronai · 2003 · Advances in cancer research
  98. p53 as an intervention target for cancer and aging
    Paul Hasty, Barbara A. Christy · 2013 · Pathobiology of Aging & Age-related Diseases
  99. Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1
    Xiao‐Xin Sun · 2014 · World Journal of Biological Chemistry
  100. Mdm2 and MdmX as Regulators of Gene Expression
    Lynn Biderman, James L. Manley, Carol L. Prives · 2012 · Genes & Cancer